SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Danaher Corp/DE – ‘10-Q’ for 7/3/20 – ‘EX-10.3’

On:  Wednesday, 7/22/20, at 6:46pm ET   ·   As of:  7/23/20   ·   For:  7/3/20   ·   Accession #:  313616-20-120   ·   File #:  1-08089

Previous ‘10-Q’:  ‘10-Q’ on 5/6/20 for 4/3/20   ·   Next:  ‘10-Q’ on 10/22/20 for 10/2/20   ·   Latest:  ‘10-Q’ on 4/23/24 for 3/29/24   ·   4 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of               Filer                 Filing    For·On·As Docs:Size

 7/23/20  Danaher Corp/DE                   10-Q        7/03/20   93:12M

Quarterly Report   —   Form 10-Q   —   Sect. 13 / 15(d) – SEA’34
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-Q        Quarterly Report                                    HTML   1.70M 
 2: EX-10.3     Agreement Regarding Competition and Protection of   HTML     61K 
                Proprietary Interests                                            
 3: EX-31.1     Certification of CEO Pursuant to Section 302        HTML     34K 
 4: EX-31.2     Certification of CFO Pursuant to Section 302        HTML     34K 
 5: EX-32.1     Certification of CEO Pursuant to Section 906        HTML     29K 
 6: EX-32.2     Certification of CFO Pursuant to Section 906        HTML     29K 
13: R1          Cover Page                                          HTML    121K 
14: R2          Consolidated Condensed Balance Sheets               HTML    133K 
15: R3          Consolidated Condensed Balance Sheets Consolidated  HTML     57K 
                Condensed Balance Sheets (Parenthetical)                         
16: R4          Consolidated Condensed Statements Of Earnings       HTML    167K 
17: R5          Consolidated Condensed Statements Of Comprehensive  HTML     63K 
                Income                                                           
18: R6          Consolidated Condensed Statement Of Stockholders'   HTML     95K 
                Equity                                                           
19: R7          Consolidated Condensed Statement Of Stockholders'   HTML     29K 
                Equity Consolidated Condensed Statement Of                       
                Stockholders' Equity (Parenthetical)                             
20: R8          Consolidated Condensed Statements Of Cash Flows     HTML    148K 
21: R9          General                                             HTML    211K 
22: R10         Revenue (Notes)                                     HTML    184K 
23: R11         Acquisitions                                        HTML     66K 
24: R12         Discontinued Operations (Notes)                     HTML     47K 
25: R13         Goodwill and Other Intangible Assets                HTML     69K 
26: R14         Fair Value Measurements                             HTML    104K 
27: R15         Financing                                           HTML    120K 
28: R16         Hedging Transactions And Derivative Financial       HTML    116K 
                Instruments (Notes)                                              
29: R17         Defined Benefit Plans                               HTML    128K 
30: R18         Income Taxes                                        HTML     56K 
31: R19         Other Income (Expense), Net and Gain on Sale of     HTML     36K 
                Product Lines                                                    
32: R20         Commitments And Contingencies                       HTML     37K 
33: R21         Stock Transactions And Stock-Based Compensation     HTML    119K 
34: R22         Net Earnings Per Common Share From Continuing       HTML     80K 
                Operations                                                       
35: R23         Segment Information                                 HTML     81K 
36: R24         General (Policies)                                  HTML     39K 
37: R25         General (Tables)                                    HTML    199K 
38: R26         Revenue (Tables)                                    HTML    167K 
39: R27         Acquisitions (Tables)                               HTML     53K 
40: R28         Discontinued Operations (Tables)                    HTML     49K 
41: R29         Goodwill and Other Intangible Assets (Tables)       HTML     68K 
42: R30         Fair Value Measurements (Tables)                    HTML     94K 
43: R31         Financing (Tables)                                  HTML    173K 
44: R32         Hedging Transactions And Derivative Financial       HTML    172K 
                Instruments (Tables)                                             
45: R33         Defined Benefit Plans (Tables)                      HTML    129K 
46: R34         Income Taxes (Tables)                               HTML     35K 
47: R35         Commitments And Contingencies (Tables)              HTML     34K 
48: R36         Stock Transactions And Stock-Based Compensation     HTML    115K 
                (Tables)                                                         
49: R37         Net Earnings Per Common Share From Continuing       HTML     74K 
                Operations (Tables)                                              
50: R38         Segment Information (Tables)                        HTML     76K 
51: R39         General (Narrative) (Details)                       HTML     51K 
52: R40         General (Components of Accumulated Other            HTML     85K 
                Comprehensive Income) (Details)                                  
53: R41         Revenue (Narrative) (Details)                       HTML     45K 
54: R42         Revenue (Disaggregation of Revenue by Geographical  HTML     80K 
                Region) (Details)                                                
55: R43         Acquisitions (Narrative) (Details)                  HTML     64K 
56: R44         Acquisitions (Pro Forma Financial Information)      HTML     51K 
                (Narrative) (Details)                                            
57: R45         Acquisitions (Fair Values Of The Assets Acquired    HTML     55K 
                And Liabilities) (Details)                                       
58: R46         Acquisitions (Pro Forma Financial Information)      HTML     36K 
                (Details)                                                        
59: R47         Discontinued Operations (Details)                   HTML     59K 
60: R48         Goodwill and Other Intangible Assets (Narrative)    HTML     36K 
                (Details)                                                        
61: R49         Goodwill and Other Intangible Assets (Rollforward   HTML     39K 
                of Goodwill) (Details)                                           
62: R50         Goodwill and Other Intangible Assets (Goodwill by   HTML     37K 
                Segment) (Details)                                               
63: R51         Goodwill and Other Intangible Assets (Schedule of   HTML     40K 
                Finite-lived Intangible Assets And                               
                Indefinite-lived Intangible Assets By Major Class)               
                (Details)                                                        
64: R52         Fair Value Measurements (Narrative) (Details)       HTML     30K 
65: R53         Fair Value Measurements (Financial Assets and       HTML     52K 
                Liabilities Carried at Fair Value) (Details)                     
66: R54         Fair Value Measurements (Carrying Amounts and Fair  HTML     51K 
                Values of Financial Instruments) (Details)                       
67: R55         Financing (Narrative) (Details)                     HTML    123K 
68: R56         Financing (Components Of Debt) (Details)            HTML    157K 
69: R57         Financing (Key Terms Of Euronotes Offering)         HTML     43K 
                (Details)                                                        
70: R58         Hedging Transactions And Derivative Financial       HTML     43K 
                Instruments (Narrative) (Details)                                
71: R59         Hedging Transactions And Derivative Financial       HTML     57K 
                Instruments (Summary of Notional Values and Pretax               
                Impact in Fair Values of Net Investment Hedges)                  
                (Details)                                                        
72: R60         Hedging Transactions And Derivative Financial       HTML     44K 
                Instruments (Derivative and Nonderivative Debt                   
                Instruments) (Details)                                           
73: R61         Defined Benefit Plans (Narrative) (Details)         HTML     34K 
74: R62         Defined Benefit Plans (Components of Net Periodic   HTML     66K 
                Benefit Cost of Defined Benefit Pension Pans)                    
                (Details)                                                        
75: R63         Defined Benefit Plans (Components of Net Periodic   HTML     46K 
                Benefit Cost of Other Postretirement Benefit                     
                Pension Pans) (Details)                                          
76: R64         Defined Benefit Plans (Components of Net Periodic   HTML     41K 
                Benefit Cost Reflected in the Consolidated                       
                Condensed Statement of Earnings) (Details)                       
77: R65         Income Taxes (Narrative) (Details)                  HTML     51K 
78: R66         Income Taxes (Summary Of Danaher's Effective        HTML     29K 
                Income Tax Rate) (Details)                                       
79: R67         Other Income (Expense), Net and Gain on Sale of     HTML     45K 
                Product Lines (Narrative) (Details)                              
80: R68         Commitments And Contingencies (Narrative)           HTML     28K 
                (Details)                                                        
81: R69         Commitments And Contingencies (Warranty Accrual)    HTML     39K 
                (Details)                                                        
82: R70         Stock Transactions And Stock-Based Compensation     HTML     90K 
                (Narrative) (Details)                                            
83: R71         Stock Transactions And Stock-Based Compensation     HTML     46K 
                (Summary of Share Activity) (Details)                            
84: R72         Stock Transactions And Stock-Based Compensation     HTML     50K 
                (Key Terms of Shares) (Details)                                  
85: R73         Stock Transactions And Stock-Based Compensation     HTML     42K 
                (Components of Stock-Based Compensation Program)                 
                (Details)                                                        
86: R74         Net Earnings Per Common Share From Continuing       HTML     34K 
                Operations (Narrative) (Details)                                 
87: R75         Net Earnings Per Common Share From Continuing       HTML     76K 
                Operations (Components of Basic and Diluted                      
                Earnings per Share) (Details)                                    
88: R76         Segment Information (Narrative) (Details)           HTML     28K 
89: R77         Segment Information (Segment Results) (Details)     HTML     58K 
91: XML         IDEA XML File -- Filing Summary                      XML    177K 
12: XML         XBRL Instance -- dhr-202073x10q_htm                  XML   3.94M 
90: EXCEL       IDEA Workbook of Financial Reports                  XLSX    122K 
 8: EX-101.CAL  XBRL Calculations -- dhr-20200703_cal                XML    233K 
 9: EX-101.DEF  XBRL Definitions -- dhr-20200703_def                 XML    771K 
10: EX-101.LAB  XBRL Labels -- dhr-20200703_lab                      XML   1.64M 
11: EX-101.PRE  XBRL Presentations -- dhr-20200703_pre               XML   1.09M 
 7: EX-101.SCH  XBRL Schema -- dhr-20200703                          XSD    172K 
92: JSON        XBRL Instance as JSON Data -- MetaLinks              437±   623K 
93: ZIP         XBRL Zipped Folder -- 0000313616-20-000120-xbrl      Zip    344K 


‘EX-10.3’   —   Agreement Regarding Competition and Protection of Proprietary Interests


This Exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



 <!   C:   C: 
  Exhibit  
Exhibit 10.3

dhrlogofor8ksa61.jpg

DANAHER CORPORATION AND ITS AFFILIATED ENTITIES AGREEMENT
REGARDING COMPETITION AND PROTECTION OF PROPRIETARY INTERESTS
I understand that I am or will be employed by Danaher Corporation or one of its affiliated entities (the “Company”). This Agreement Regarding Competition and Protection of Proprietary Interests (“Agreement”) is between me, the undersigned employee, and the Company, on behalf of and for the benefit of itself and all entities owned in whole or in part by Danaher Corporation or its subsidiaries or affiliates (the “Danaher Companies”). In consideration of (i) my employment or continued employment; (ii) access to the Company’s key business relationships and Confidential Information described herein (including but not limited to the Danaher Business System); (iii) the ability to participate in Company-sponsored programs or plans; (iv) a salary increase, equity grant, and/or other increase to my total compensation package provided concurrently with my execution of this Agreement; and/or (v) other good and valuable consideration provided to me, I agree to the following restrictions, which I acknowledge are reasonable and necessary to protect the Company’s interests.
1.    Protection of Confidential Information.
a.    Definition of “Confidential Information.” The term “Confidential Information” means any information about the Company’s business or employees that is not generally known to the public, including but not limited to trade secrets. Examples of Confidential Information include, but are not limited to, information about: Danaher Business System (including but not limited to DBS training materials, materials describing DBS processes, materials describing DBS growth and innovation tools, DBS processes related to mergers and acquisitions, strategic plans, value stream mapping information, transactional process improvement reports and analyses, problem solving process information, Voice of the Customer reports and analyses, talent reviews and organizational plans, and methodology for developing DBS tools and standard work), customers, vendors, pricing and costs, business strategies and plans, financial data, technology, talent reviews and organizational plans, research and development and any other businesses methods or processes used or considered by the Company. Confidential Information does not include any specific information that has been voluntarily disclosed to the public by the Company or that has been independently developed and disclosed by others, or that otherwise has entered the public domain through lawful means. However, Confidential Information disclosed by me or others without authorization by the Company shall not be deemed “voluntarily disclosed to the public.”
b.    Nondisclosure and Prohibition against Misuse. During my employment, I will not use or disclose any Confidential Information, without the Company’s prior written permission, for any purpose other than performance of my duties for the Company or as set forth in Section 4 below.
c.     Non-Disclosure and Return of Property Upon Termination. After my employment ends, I will not use or disclose any Confidential Information for any purpose, including utilizing or incorporating any confidential or proprietary aspects of the Danaher Business System that the Company disclosed to me during my employment with the Company. Immediately upon my employment termination, I will return to the Company all Company property that I have in my possession, custody, or control, including, without limitation, any Confidential Information. If I have Confidential Information that has been saved or transferred to any device not owned by the Company, I will immediately notify the Company, and make such device available to the Company so that it may remove any Confidential Information from the device.
2.    Protection of Company Interests.
a.
Definitions.
(1)
“Competing Organization” means an entity that manufactures, sells, or distributes Competing Products in the Restricted Territory, including, by way of example only and without limitation, the companies identified from time to time as peer companies in the annual proxy statements the Company files with the U.S. Securities and Exchange Commission;

(2)
“Competing Products” means (i) products or services similar to or competitive with the products or services sold by the Company for which I had any responsibility during the 24 months preceding my employment termination (“Pre-Termination Period”); (ii) products or services similar to or competitive with any prospective product or service the Company took steps to develop and for which I had any responsibility during the Pre-Termination Period; and (iii) products or services that utilize or incorporate Confidential Information, including, without limitation, Danaher Business System information.
(3)
“Solicit” means: (i) any comments, conduct or activity that would influence a customer’s decision to continue doing business with the Company, regardless of who initiates contact; and (ii) any comments, conduct or activity




that would influence an employee’s decision to resign his employment with the Company or accept employment with me or my new employer, regardless of who initiates contact.
(4)
“Restricted Customer” means a customer or prospective customer of the Company (i) with whom I had contact or with whom I dealt on behalf of the Company during the Pre-termination Period (defined above); (ii) whose dealings with the Company I coordinated or supervised during the Pre-termination Period; (iii) about whom I obtained Confidential Information during the Pre-Termination Period; or (iv) who received products or services that resulted in compensation, commissions, or earnings for me during the Pre-Termination Period.
(5)
“Restricted Territory” means any geographic territory (i) in which I performed services for the Company during the Pre-Termination Period; (ii) over which I had sales or management responsibilities for the Company during the Pre-Termination Period; (iii) in which the Company employed or engaged personnel that I directly or indirectly supervised or managed during the Pre-Termination Period; or (iv) about which I had access to Confidential Information during the Pre-Termination Period.
b.    Non-Competition. During my employment I will not engage in any other employment, occupation, consulting or other business activity that competes with or conflicts with my obligations to the Company. Without limiting the foregoing, for 24 months after my employment termination, I will not directly or indirectly, on behalf of myself or in conjunction with any other person or entity:
(1)
own any Competing Organization (other than less than 3% ownership in a publicly traded company); or
(2)
work in the Restricted Territory for any Competing Organization in any role: (i) that involves responsibilities related to the sale of Competing Products; or (ii) developing or implementing strategies to compete with the Company with respect to Competing Products; or (iii) directly or indirectly supervising or managing employees or other personnel who compete with the Company with respect to Competing Products; or (iv) utilizing or disclosing Confidential Information.
c.    Non-Solicitation of Customers. During my employment and for 24 months after my employment termination, I will not directly or indirectly, on behalf of myself or in conjunction with any other person or entity, solicit or accept business from any Restricted Customer if the products or services that customer intends to purchase are Competing Products.
d.    Non-Solicitation of Employees. During my employment and for 24 months after my employment termination, I will not directly or indirectly, on behalf of myself or in conjunction with any other person or entity, hire, solicit, recruit, induce, or attempt to hire, solicit, recruit, or induce any employee or independent contractor of the Company, who worked for the Company during the 6 months preceding my employment termination, to work for me or my new employer.
e.    Limitations on Working for Customers and Vendors. During my employment, and for 12 months after termination of my employment, I will not work for any customers or vendors of the Company in any role in which I would use or disclose or threaten to use or disclose Confidential Information.
f.    Return of Property and Copying. I agree that all tangible materials (whether originals or duplicates), including but not limited to, notebooks, computers, files, reports, proposals, price lists, lists of actual or potential customers or suppliers, talent lists, formulae, prototypes, tools, equipment, models, specifications, technical data, methodologies, research results, test results, financial data, contracts, agreements, correspondence, documents, computer disks, software, computer printouts, information stored electronically, memoranda, and notes, in my possession or control which in any way relate to the Company’s business and which are furnished to me by or on behalf of the Company or which are prepared, compiled or acquired by me while working with or employed by the Company shall be the sole property of the Company. I will at any time upon the request of the Company and in any event promptly upon termination of my employment or relationship with the Company, but in any event no later than two (2) business days after such termination, deliver all such materials to the Company and will not retain any originals or copies of such materials, whether in hard copy form or as computerized and/or electronic records. Except to the extent approved by the Company or required by my bona fide job duties for the Company, I also agree that I will not copy or remove from the Company’s place of business or the place of business of a customer of the Company, property or information belonging to the Company or the customer or entrusted to the Company or the customer. In addition, I agree that I will not provide any such materials to any competitor of or entity seeking to compete with the Company unless specifically approved in writing by the Company. Without limitation of the foregoing, and for the avoidance of doubt, I acknowledge and agree that my obligation to return all such Company materials in this Section include, but are not limited to, any and all materials relating to the Danaher Business System.)
3.    Non-Disparagement. I agree that during my employment, and after my employment with the Company ends, I will not make any false statement(s) about the Company to other employees, customers, vendors or any other third party.
4.    Limitations on Confidentiality and Non-Disparagement. The confidentiality and non-disparagement provisions in this Agreement do not prohibit me from providing truthful information in good faith to any federal or state governmental agency, entity or official investigating an alleged violation of federal or state law or regulation or when I make other disclosures that are protected under applicable law, including, without limitation, the National Labor Relations Act, the Defend Trade Secrets Act,




and any rule or regulation promulgated by the Securities and Exchange Commission (SEC), the National Labor Relations Board (NLRB), the Equal Employment Opportunity Commission (EEOC), or any other federal, state, or local government agency.
5.    Other Legal Obligations. Nothing in this Agreement relieves me of any duties or obligations that I have to the Company under statutory or common law, which include but are not limited to: fiduciary duties, the duty of loyalty, the duty not to tortiously interfere with business relationships, the duty not to engage in unfair competition, and the duty not to misappropriate trade secrets.
6.    Subsequent Employment Protocol. During my employment and for 24 months after termination of my employment, prior to accepting employment with any person or entity, I will provide my prospective employer with a copy of this Agreement, and I consent to the Company’s right, at any time, to notify such employer of this Agreement, as well as the details of any alleged violations thereof. Additionally, within three calendar days after accepting any employment with another employer, I will notify the Company of such subsequent employer’s name, address and telephone number, and the title and description of the job duties for which I have accepted employment.
7.    Certifications. By executing this Agreement, I certify that I: (a) have not and will not use or disclose to the Company any confidential information and/or trade secrets belonging to others, including my prior employers; (b) will not use any prior inventions made by me and which the Company is not legally entitled to learn of or use; and (c) am not subject to any prior agreements that would prevent me from fully performing my duties for the Company.
8.    Protection of Proprietary Rights.
a.I agree that all Work Product (defined below) and Intellectual Property Rights (defined below) shall be the sole and exclusive property of the Company. “Work Product” means all writings, inventions, discoveries, ideas and other work product of any nature whatsoever that I create on my own or in collaboration with others during my employment with the Company and that relates to the business, contemplated business, research or development of the Company. “Intellectual Property Rights” means all rights in and to copyrights, trade secrets, trademarks (and related goodwill), patents and other intellectual property rights arising out of the Work Product, in any jurisdiction throughout the world, and all related rights of priority under international conventions.
b.I acknowledge that, by reason of being employed by the Company, all of the Work Product is, to the extent permitted by law, “work made for hire” and is the property of the Company. To the extent that any Work Product is not “work made for hire,” I hereby irrevocably assign to the Company, for no additional consideration, my entire right, title and interest in and to all Work Product and Intellectual Property Rights therein.
c.During and after my employment, I agree to reasonably cooperate with the Company to (i) apply for, obtain, perfect and transfer to the Company the Work Product and any Intellectual Property Rights in the Work Product in any jurisdiction in the world; and (ii) maintain, protect and enforce the same. I hereby irrevocably grant the Company power of attorney to execute and deliver any such documents on my behalf and in my name and to do all other lawfully permitted acts to transfer the Work Product to the Company and further the transfer, issuance, prosecution and maintenance of all Intellectual Property Rights therein, to the full extent permitted by law, in the event that I don’t promptly cooperate with the Company’s request. The power of attorney is coupled with an interest and shall not be affected by my subsequent incapacity.
d.I represent and warrant that I am not a party to any agreements which would limit my ability to assign Work Product or Intellectual Property Rights as required by this Section 8.
e.I have identified in the space below (and have attached additional paper as needed) all Work Product and Intellectual Property in which I have any right, title or interest, and which were developed by me prior to my employment with the Company and which relate to the actual or anticipated business or research or development of the Company as provided for in this Section 8.

________________________________________________________________________________________________
________________________________________________________________________________________________
________________________________________________________________________________________________

9.    Injunctive Relief and Attorney’s Fees. I agree that in the event I breach this Agreement, the Company will be irreparably harmed and entitled to an injunction restraining any further breach, in addition to any other rights to which it is entitled. Further, I will be responsible for all reasonable attorneys’ fees, costs and expenses incurred by the Company if it successfully enforces any portion of this Agreement against me. Additionally, any time periods for restrictions set forth in Section 2 above will be extended by an amount of time equal to the duration of any time period during which I am in violation of this Agreement.
10.    Modification & Severability. If any portion of this Agreement shall be held unenforceable, the parties agree that a court of competent jurisdiction may modify the agreement (by adding or removing language) or sever unenforceable provisions in order to render this Agreement enforceable to the fullest extent permitted by law.




11.    At-Will Employment Status. I acknowledge and agree that that nothing in this Agreement alters my status as an employee at will.
12.    Assignment. This Agreement is personal to me and I may not assign it. The Company may assign it to any assign, or a successor to all or substantially all of the business or assets of the Company, and no further consent from me is necessary. If I previously executed any written agreements with Danaher Corporation of its affiliates that contain provisions similar to the provisions contained in this Agreement, I hereby consent to the assignment of those agreements to the Company.
13.    Change of Position. If the Company changes my position or title with the Company, or my employment changes from one Danaher Company to another, this Agreement and my obligations hereunder will remain in force.
14.    Protections for Affiliates and Subsidiaries. This Agreement is intended to benefit all Danaher subsidiaries and affiliates for which I perform services, for which I have customer contact or about which I receive Confidential Information. Therefore, any Danaher Company that may be adversely affected by a breach, and any successor or assignee of such Danaher Company may enforce this Agreement regardless of which entity actually employs me at the time.
15.    Cooperation. Both during and after my employment with the Company, I will cooperate with the Company and any other Danaher Company in connection with any investigation or litigation in which the Company believes that I am an individual with knowledge concerning the subject matter of the investigation or litigation. In particular, but without limitation, I will make myself available for meetings, interviews, depositions, and court appearances, as requested by the Company, and to otherwise assist the Company or any other Danaher Company in connection with any such investigation or litigation. I acknowledge that I have been notified in accordance with the Defend Trade Secrets Act of 2016 that I will not be held criminally or civilly liable under any federal or state trade secret law for the disclosure of a trade secret that: (a) is made (i) in confidence to a federal, state, or local government official, either directly or indirectly, or to an attorney; and (ii) solely for the purpose of reporting or investigating a suspected violation of law; or (b) is made in a complaint or other document that is filed under seal in a lawsuit or other proceeding. I further acknowledge that I have been notified that if I file a lawsuit for retaliation against the Company for reporting a suspected violation of law, I may disclose the Company’s trade secrets with my attorney and use the trade secret information related to that suspected violation of law in the court proceeding if I: (a) file any document containing the trade secret under seal; and (b) do not disclose the trade secret, except pursuant to court order.
16.    Other Agreements. If I executed other written agreements relating to this subject matter with the Company, any other Danaher Company, or Danaher Corporation or any of its affiliates, and/or if I later enter into other written agreements that contain provisions similar to the provisions contained in this Agreement, and/or if I am a participant in any benefit plan of Danaher Corporation or any of its affiliates, all such provisions shall be interpreted to provide the Company with cumulative rights and remedies and the benefits and protections provided to the Company under each such agreement shall be given full force and effect.
17.    Governing Law. This Agreement shall be governed by and construed in accordance with the laws of the State of Delaware, without applying its conflict of laws principles. The exclusive venue for any litigation based upon any fact, matter or claim arising out of or relating to this Agreement, including any contractual, statutory, tort, or common law claims, shall be the state or federal courts located in Delaware and I hereby consent to any such court’s exercise of personal jurisdiction over me for such purpose.


Agreed to by:


/s/ Joakim Weidemanis___________________        /s/ Sarah Smith________________________________
Signature                         Danaher Corporation

Joakim Weidemanis_____________________        Sarah Smith - VP Corporate HR
Printed Name                        Print Name and Title


Date:     5/15/20                        Date:     5/20/20






4 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 2/21/24  Danaher Corp./DE                  10-K       12/31/23  147:77M
 2/22/23  Danaher Corp./DE                  10-K       12/31/22  138:85M
 2/23/22  Danaher Corp./DE                  10-K       12/31/21  141:89M
 2/25/21  Danaher Corp./DE                  10-K       12/31/20  153:22M
Top
Filing Submission 0000313616-20-000120   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Thu., May 16, 6:22:02.1am ET